期刊文献+

替米沙坦对原发性高血压患者动脉弹性的影响 被引量:2

Effect of Telmisartan Treatment on Artery Elasticity in Essential Hypertension
原文传递
导出
摘要 目的研究替米沙坦对原发性高血压患者动脉弹性的影响,探讨替米沙坦对动脉血管弹性病理性降低的逆转机制。方法入选原发性高血压患者127例,应用替米沙坦80 mg.d 1治疗3个月,测定患者治疗前后血清一氧化氮、血清瘦素水平及观察大、小动脉弹性指数。结果替米沙坦治疗3个月,原发性高血压患者总体血压水平下降(P<0.05),达到降压治疗的目的。替米沙坦极显著性降低血清瘦素水平(P<0.01),显著提高血清一氧化氮浓度(P<0.05),并提升大动脉弹性指数和小动脉弹性指数(P<0.01)。结论替米沙坦能控制原发性高血压并改善动脉弹性。 OBJECTIVE To discuss the effect of telmisartan treatment on artery elasticity in essential hypertension(EH) and to investigate the mechanism of telmisartan that reverse the pathological changes of artery elasticity. METHODS Totally 127 patients with essential hypertension were chosen to be treated with telmisartan(80 mg.d^-1) for 3 months. The serum levels of leptin and nitric oxide, large artery elasticity index and small artery elasticity index were determined in pre- and post-treatment. RESULTS After 3 months of treatment by telmisartan overall blood pressure levels in patients with essential hypertension (P〈0.05) were achieve antihypertensive treatment goal, very significantly reduced serum leptin level (P〈0.01), notably improved the serum levels of nitric oxide (P〈0.05), and significant lifted large and small artery elasticity index(P〈0.01). CONCLUSION Telmisartan can control essential hypertension and improve artery elasticity.
出处 《中国现代应用药学》 CAS CSCD 2012年第6期554-557,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 替米沙坦 原发性高血压 动脉弹性 一氧化氮 瘦素 telmisartan essentail hypertension arteryl elasticity NO leptin
  • 相关文献

参考文献4

二级参考文献56

  • 1Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue[ J]. Nature, 1994,372 (6505) :425-432.
  • 2Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular disorders : disturbance of the regulatory system ocnsisting of humoral and neuronal signals [ J ]. Circ Res ,2007,101 ( 1 ) :27-39.
  • 3Winters B,Mo Z,Brooks-Asplund E, et al. Reduction of obesity,as induced by leptin, reverses endothelial dysfunction in obese (Lep (ob)) mice[J]. J Appl Physiol,2000,89(6) :2382-2390.
  • 4Lembo G, Vecchione C, Fratta L,et al. Leptin induces direct vasodilation through distinct endothelial mechanisms [J]. Diabetes, 2000,49(2) :293-297.
  • 5Quehenberger P, Exner M, Sunder-Plassmann R, et al. Leptin induces endothelin-1 in endothelial cells in vitro [J]. Circ Res, 2002,90(6) :711-718.
  • 6Eikelis N, Schlaich M, Aggarwal A, et al. Interactions between leptin and the human sympathetic nervous system [ J ]. Hypertension, 2003,41 (5) : 1072-1079.
  • 7Correia ML, Rahmouni K. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome [ J ]. Diabetes Obes Metab, 2006,8 ( 6 ) : 603-610.
  • 8Rahmouni K, Morgan DA, Morgan GM, et al. Role of selective leptin resistance in diet-induced obesity hypertension [ J ]. Diabetes, 2005,54 ( 7 ) :2012-2018..
  • 9Agata J, Masuda A, Takada M, et al. High plasma immunoreactive leptin level in essential hypertension [ J ]. Am J Hypertens, 1997, 10(10 Pt 1) :1171-1174.
  • 10Luo JD, Zhang GS, Chen MS. Leptin and cardiovascular diseases [ J ]. Timely Top Med Cardiovasc Dis, 2005,9 ( 12 ) : E34.

共引文献16

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部